Acetazolamide Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-853

2 FDA label images from Mylan Institutional Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 67457-853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ace0d 0000 01)

Chemical Structure (Ace0d 0000 01)
Chemical structure diagram of acetazolamide sodium, showing its molecular formula and atomic arrangement as labeled.*
FDA Label Image

Carton (Image 01)

Carton (Image 01)
The image shows the packaging label for Acetazolamide Injection, USP 500 mg, lyophilized powder for solution, for intravenous use. The label includes storage instructions, manufacturer information (Mylan Institutional LLC), product NDC 67457-853-50, and specifies one vial per package. The label highlights that the product is sterile, preservative-free, nonpyrogenic, and for Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.